Valacyclovir HCl (hydrochloride) is a prescription antiviral medication used to treat infections caused by certain types of herpes viruses. It is FDA-approved for cold sores, genital herpes, shingles, and chickenpox. Sold under the brand name Valtrex, it works by slowing the growth and spread of the virus so your body can fight off the infection more effectively.
Conditions Valacyclovir Treats
Valacyclovir covers a range of herpes virus infections across different age groups. In adults, it is approved for:
- Cold sores (herpes labialis), caused by herpes simplex virus type 1
- Genital herpes, including first episodes, recurrent outbreaks, daily suppressive therapy, and reduction of transmission to a partner
- Shingles (herpes zoster), the painful rash caused by reactivation of the chickenpox virus
For children and teens, it is approved for cold sores in patients 12 and older and for chickenpox in children ages 2 through 17. It does not cure any of these infections. Herpes viruses remain dormant in the body, and valacyclovir controls active outbreaks or helps prevent them from recurring.
How It Works in the Body
Valacyclovir is a prodrug, meaning your body converts it into the active compound acyclovir after you swallow it. The key advantage of valacyclovir over taking acyclovir directly is absorption: your body takes in about 45% of the drug from valacyclovir tablets, compared to roughly 27% from acyclovir tablets. That 68% improvement in absorption means you can take fewer pills per day and still maintain effective drug levels.
Once converted, acyclovir targets only cells that are actively infected. Infected cells contain a virus-produced enzyme that activates the drug inside the cell. The activated drug then mimics a building block of DNA and gets incorporated into the virus’s genetic material as it tries to copy itself. This stops the viral DNA chain in its tracks. The viral copying machinery binds tightly to the incomplete chain and is essentially shut down. Because uninfected cells lack that viral enzyme, they are largely left alone, which is why the drug is well tolerated.
Genital Herpes: Outbreaks and Suppression
Valacyclovir can be used in two distinct ways for genital herpes. For active outbreaks, a short course of treatment shortens the duration of sores and reduces discomfort. Starting treatment at the first sign of tingling or blistering makes a meaningful difference in how quickly symptoms resolve.
Daily suppressive therapy is the other approach, typically used by people who experience frequent recurrences. Taking valacyclovir every day reduces the frequency of outbreaks by 70% to 80%. It also lowers the risk of passing the virus to a sexual partner. In a large study published in the New England Journal of Medicine, source partners taking daily valacyclovir shed the virus on only about 3% of days, compared to nearly 11% of days on placebo. The CDC recommends daily suppressive therapy as a strategy for reducing transmission in couples where one partner has genital herpes and the other does not.
Shingles and Timing of Treatment
For shingles, valacyclovir shortens both the rash and the lingering nerve pain that can follow. It outperforms its predecessor acyclovir in resolving shingles-related pain. In patients 50 and older, treatment with valacyclovir resolved pain about a week sooner than acyclovir, with median pain duration around 44 days versus 51 days when treatment was started within 48 hours of rash onset.
Starting treatment early matters, but even beginning within 72 hours of the rash appearing still provides a significant benefit. The medication is typically taken for seven days. Because shingles pain can persist for weeks or months after the rash clears (a condition called postherpetic neuralgia), faster resolution of that pain is one of the main reasons valacyclovir is preferred.
Cold Sores
For cold sores, valacyclovir is used as a short burst of treatment at the earliest sign of an outbreak, ideally when you first notice the tingling or burning sensation before a blister forms. This approach can shorten the duration of a cold sore by about a day. It is approved for adults and for adolescents ages 12 and up.
Common Side Effects
Valacyclovir is generally well tolerated. The most frequently reported side effects in clinical trials were headache, nausea, and abdominal pain, all occurring in more than 10% of patients in at least one of the studied conditions. The rates varied by condition:
- Headache was the most common side effect across all uses, reported by 13% to 38% of patients depending on the condition and dosing. Placebo groups also reported headache at high rates (8% to 34%), so a portion of this is simply background occurrence.
- Nausea was most notable in shingles treatment, affecting about 15% of patients compared to 8% on placebo.
- Abdominal pain showed up most during long-term suppressive therapy, at around 11% versus 6% with placebo.
In teens treated for cold sores, headache (17%) and nausea (8%) were the primary concerns. In younger children treated for chickenpox, diarrhea (5%) and fever (4%) were the most common reactions. Serious side effects are rare but can include kidney problems, particularly in people who are already dehydrated or have pre-existing kidney issues. Staying well hydrated while taking the medication helps reduce this risk.
How It Differs From Other Antivirals
Valacyclovir, acyclovir, and famciclovir all target the same family of viruses, and they all work by disrupting viral DNA replication. The practical difference comes down to convenience. Acyclovir, the oldest of the three, requires more frequent dosing throughout the day because less of it reaches your bloodstream. Valacyclovir’s improved absorption means fewer daily doses for the same effect, which makes it easier to stick with treatment, especially during long-term suppressive therapy. Your prescriber may choose among these options based on your specific condition, how often you have outbreaks, and how your kidneys are functioning.